Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G MacGregor

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
British Medical Journal (Clinical Research Ed.)|December 12, 1981
Synergistic action of metolazone and frusemideE Brown, G MacGregor
Human Factors|August 1, 1989
Perception of risk in automotive systemsD G MacGregor, P Slovic
Annals of Eugenics|February 19, 2014
Congenital total colour blindness associated with otosclerosisA G MACGREGOR, R HARRISON
Risk Analysis : an Official Publication of the Society for Risk Analysis|December 1, 1996
Risk perception and symptom reportingD G MacGregor, R Fleming
British Journal of Pharmacology|June 1, 1993
Inhibition by the adenosine analogue, (R-)-N6-phenylisopropyladenosine, of kainic acid neurotoxicity in rat hippocampus after systemic administrationD G MacGregor, T W Stone
Neuroreport|June 1, 1992
Prevention of kainate-induced excitotoxicity by a purine analogueD G MacGregor, T W Stone
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|May 5, 2012
Scholarship success: Umthombo Youth Development FoundationA J Ross, R G MacGregor
International Journal of Epidemiology|May 1, 2002
Salt, blood pressure and healthG MacGregor, H E de Wardener
JID Innovations : Skin Science From Molecules to Population Health|May 7, 2025
The PAR2 Antagonist Larazotide Can Mitigate Acute Histamine-Stimulated Epithelial Barrier Disruption in Keratinocytes: A Potential Adjunct Treatment for Atopic DermatitisDanielle M Glinka, Gordon G MacGregor
Brain Research|May 2, 1994
Blockade by 1,3-dipropyl-8-cyclopentylxanthine (CPX) of purine protection against kainate neurotoxicityD G Macgregor, T W Stone
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
British Medical Journal (Clinical Research Ed.)|December 12, 1981
Synergistic action of metolazone and frusemideE Brown, G MacGregor
Human Factors|August 1, 1989
Perception of risk in automotive systemsD G MacGregor, P Slovic
Annals of Eugenics|February 19, 2014
Congenital total colour blindness associated with otosclerosisA G MACGREGOR, R HARRISON
Risk Analysis : an Official Publication of the Society for Risk Analysis|December 1, 1996
Risk perception and symptom reportingD G MacGregor, R Fleming
British Journal of Pharmacology|June 1, 1993
Inhibition by the adenosine analogue, (R-)-N6-phenylisopropyladenosine, of kainic acid neurotoxicity in rat hippocampus after systemic administrationD G MacGregor, T W Stone
Neuroreport|June 1, 1992
Prevention of kainate-induced excitotoxicity by a purine analogueD G MacGregor, T W Stone
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|May 5, 2012
Scholarship success: Umthombo Youth Development FoundationA J Ross, R G MacGregor
International Journal of Epidemiology|May 1, 2002
Salt, blood pressure and healthG MacGregor, H E de Wardener
JID Innovations : Skin Science From Molecules to Population Health|May 7, 2025
The PAR2 Antagonist Larazotide Can Mitigate Acute Histamine-Stimulated Epithelial Barrier Disruption in Keratinocytes: A Potential Adjunct Treatment for Atopic DermatitisDanielle M Glinka, Gordon G MacGregor
Brain Research|May 2, 1994
Blockade by 1,3-dipropyl-8-cyclopentylxanthine (CPX) of purine protection against kainate neurotoxicityD G Macgregor, T W Stone
Pageof 10